Elevra Lithium Limited: Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) signed a binding 7-year spodumene supply deal with Mangrove Lithium, extendable for another 7 years. The agreement covers 122,000 tonnes annually, with a floor price above Elevra's production costs and no ceiling. Both companies are backed by the Canada Growth Fund, aiming to strengthen Canada's lithium supply chain. Mangrove must reach a final investment decision by 2028.

Original reporting
Published Aug 21, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 2:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ELVR
Bullish
high confidence
Mentioned
$ELVR
Relevance
7/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

The binding agreement secures a key customer, adds revenue certainty, and introduces upside without a price ceiling.

02

Market read

First disclosure of a multi‑year off‑take contract that could positively influence ELVR's valuation and the broader lithium sector.

03

What to watch

Potential regulatory changes or cost overruns at NAL could affect profitability despite the floor price.

Relevance 7/10Novelty 7/10Timing: announcement today

Background

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) operates North American Lithium in Québec and seeks to lock in downstream demand.

Company-level read

Ticker impact

$ELVRBullishHigh confidence
Context

Elevra Lithium announced a binding seven‑year supply agreement for spodumene concentrate with Mangrove Lithium, securing a long‑term customer and price floor.

Expected impact

potential modest upside as the deal adds stable demand and margin protection.

Evidence & confidence

First‑report of a sizable multi‑year supply deal with floor price above cost; market typically rewards secured off‑take agreements.

Market effects

strengthens the North American lithium supply chain, benefiting battery manufacturers and related miners.

supports Canadian lithium sector sentiment and may boost related junior miners.

adds to global lithium supply confidence, modestly influencing commodity outlook.

Counterpoint

If financing for Mangrove's conversion plant stalls, the contract could be delayed, limiting upside.

Key entities

  • Elevra Lithium Limited

    North American lithium producer announcing the supply agreement.

  • Mangrove Lithium

    Lithium refining technology firm securing feedstock for its planned conversion facility.

Related articles

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.

$ELVRMed

Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) finalized a binding supply agreement with Mangrove Lithium for long-term spodumene concentrate supply from its North American Lithium facility in Québec. The deal follows a previous MoU and includes a price floor above production costs and no price ceiling. Elevra aims to avoid seaborne freight costs by supplying a local customer.

$ELVRMed

Elevra Lithium Q4 Earnings Call Highlights

Elevra Lithium (NASDAQ:ELVR) reported June-quarter revenue of $31 billion and average realized price of $921 per tonne, with unit operating costs of $907 per tonne. Full-year unit operating costs were $853 per tonne, below revised guidance of $860 to $880. The company raised $207 million net from equity and $145 million CAD via convertible notes, funded NAL expansion, and expects higher shipping volumes.

$ELVRMed

Elevra Lithium Quarterly Activities Report

Elevra Lithium Limited (ASX: ELV, NASDAQ: ELVR) reported June 2026 quarter results for North American Lithium. Ore mined was 372,938 wmt, process plant utilisation 92%, lithium recoveries 71%, and spodumene concentrate 54,479 dmt. Spodumene sales were 33,977 dmt at US$921/dmt for US$31m revenue. Elevra also announced a US$196m placement plus US$102m convertible notes to fund the NAL expansion, and said cash was US$255m at quarter end.

$ELVRMed

Elevra Lithium Limited (ASX:ELV) EGM - Chair Address and EGM Slides

Elevra Lithium Limited (ASX:ELV, NASDAQ:ELVR, OTC:SYAXF) said at its 2026 EGM it plans a three-stage North American Lithium brownfield expansion to raise annual spodumene concentrate capacity to 338ktpa by 2029. It targets 4,500 tpd milling throughput in Stage 1, 6,500 tpd by 2028 in Stage 2, and lower unit costs in Stage 3. The A$508M funding package includes A$275M equity, A$146M convertible notes from Canada Growth Fund, and about A$87M net proceeds from divesting Ghana’s Ewoyaa. The updated